7Baggers
 High Growth Tech Stocks In The US Market With Promising Potential  simplywall.st Mon, 29 Sep 2025 11:15:27 GMT
 aldeyra therapeutics stock surges on key regulatory advancements  AD HOC NEWS Sat, 27 Sep 2025 04:27:03 GMT
 strs ohio takes position in aldeyra therapeutics, inc. $aldx  MarketBeat Tue, 23 Sep 2025 07:16:01 GMT
 published on: 2025-09-08 19:00:28  beatles.ru Mon, 08 Sep 2025 16:02:24 GMT
 aldeyra therapeutics (aldx) stock price, news & analysis  MarketBeat Fri, 05 Sep 2025 19:18:45 GMT
 published on: 2025-09-02 14:47:49  Newser Tue, 02 Sep 2025 19:47:49 GMT
 High Growth Tech Stocks To Watch In US August 2025  simplywall.st Fri, 29 Aug 2025 07:00:00 GMT
 ema grants orphan designation to aldeyra’s adx-2191 for vitreoretinal lymphoma  Pharmaceutical Business review - Fri, 29 Aug 2025 07:00:00 GMT
 aldeyra receives orphan designation from ema for adx-2191  TipRanks Thu, 28 Aug 2025 12:33:09 GMT
 Intravitreal Methotrexate Fast Tracked for Retinitis Pigmentosa  Optometry Advisor Tue, 26 Aug 2025 07:00:00 GMT
 high growth tech stocks in the us market to watch  simplywall.st Tue, 26 Aug 2025 07:00:00 GMT
 published on: 2025-08-22 05:35:22  beatles.ru Fri, 22 Aug 2025 01:35:22 GMT
 8 best us stocks under $10 to invest in  Insider Monkey Thu, 21 Aug 2025 23:45:32 GMT
 published on: 2025-08-21 15:18:06  beatles.ru Thu, 21 Aug 2025 11:18:06 GMT
 published on: 2025-08-21 07:52:25  더경남뉴스 Thu, 21 Aug 2025 00:18:28 GMT
 aldeyra  AInvest Wed, 20 Aug 2025 07:00:00 GMT
 aldeyra therapeutics receives fast track designation for adx?219  GuruFocus Tue, 19 Aug 2025 11:45:12 GMT
 aldeyra granted fast track designation for adx-2191 by fda  TipRanks Tue, 19 Aug 2025 11:44:41 GMT
 Don't Ignore The Insider Selling In Aldeyra Therapeutics  simplywall.st Tue, 19 Aug 2025 07:00:00 GMT
 FDA grants fast track designation for Aldeyra’s eye disease drug  Investing.com Tue, 19 Aug 2025 07:00:00 GMT
 aldeyra therapeutics gains fda fast track for adx-2191  TipRanks Tue, 19 Aug 2025 07:00:00 GMT

Aldeyra Therapeutics, Inc
(NASDAQ:ALDX) 

ALDX stock logo

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, an ophthalmic solution, which is in Phase III clinical trial for the treatment of dry eye diseases and alle...

Founded: 2004
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends